Author: Go, Seong Woo; Kim, Boo Kyeong; Lee, Sung Hak; Kim, Tae-Jung; Huh, Joo Yeon; Lee, Jong Min; Hah, Jick Hwan; Kim, Dong Whi; Cho, Min Jung; Kim, Tae Wan; Kang, Ji Young
                    Title: Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis  Cord-id: y8z8gkpb  Document date: 2013_12_24
                    ID: y8z8gkpb
                    
                    Snippet: Imatinib mesylate is a targeted therapy that acts by inhibiting tyrosine kinase of the bcr-abl fusion oncoprotein, which is specific to chronic myeloid leukemia (CML), and the c-transmembrane receptor, which is specific to gastrointestinal stromal tumors. Interstitial pneumonitis is a rare adverse event of imatinib therapy. It is clinically difficult to distinguish from infectious pneumonia, which can frequently occur due to the underlying disease. The standard treatment for imatinib-induced pne
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Imatinib mesylate is a targeted therapy that acts by inhibiting tyrosine kinase of the bcr-abl fusion oncoprotein, which is specific to chronic myeloid leukemia (CML), and the c-transmembrane receptor, which is specific to gastrointestinal stromal tumors. Interstitial pneumonitis is a rare adverse event of imatinib therapy. It is clinically difficult to distinguish from infectious pneumonia, which can frequently occur due to the underlying disease. The standard treatment for imatinib-induced pneumonitis is to discontinue the medication and optionally administer corticosteroids. However, there are a few cases of successful retrial with imatinib. We describe a case of successful rechallenge of imatinib in a patient with imatinib-induced interstitial pneumonitis and CML without a recurrence of the underlying disease after 3 months of follow-up.
 
  Search related documents: 
                                Co phrase  search for related documents- abdominal neck and adeno virus: 1
  - abdominal neck and lung biopsy: 1
  - abnormal dyspnea and adeno virus: 1
  - abnormal dyspnea and lung biopsy: 1, 2
  - abnormal dyspnea and lung disease: 1, 2
  - adeno virus and lung biopsy: 1
  - adeno virus and lung histology: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date